• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Fashion Optical Displays' catalog highlights dispensary designs, furnishings

Article

Fashion Optical Displays presents its latest Master Catalog featuring new dispensary designs and furnishing collections. The 132-page catalog showcases the company's newest product lines, including the Oasis, Aspire, and Paramount collections of contemporary and traditional dispensary displays and furnishings.

Fashion Optical Displays presents its latest Master Catalog featuring new dispensary designs and furnishing collections. The 132-page catalog showcases the company's newest product lines, including the Oasis, Aspire, and Paramount collections of contemporary and traditional dispensary displays and furnishings.

Other new offerings include the Concorde three-point frame support merchandising system and the Shadow Reduction Technology (SRT) frame display panels that virtually remove shadows caused by lighting.

For more information, visit Fashion Optical Displays at Booth 2601.

Related Videos
 John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks with Ophthalmology Times Europe's® Caroline Richards
rande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion with Ophthalmology Times®' Sheryl Stevenson
What keeps you up at night?
S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon
Caesar Luo, MD, shares his key take-aways on diabetic retinopathy progression in anti-VEGF versus FA implant
© 2024 MJH Life Sciences

All rights reserved.